These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 548991)

  • 1. Are erythropoietin levels in uraemic patients on haemodialysis dependent on the kidney disease and the duration of haemodialysis treatment?
    Walle AJ; Niedermayer W
    Proc Eur Dial Transplant Assoc; 1979; 16():481-6. PubMed ID: 548991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a dissociation of erythropoietic proliferation and serum erythropoietin levels in renal failure patients on longterm haemodialysis treatment.
    Walle AJ; Niedermayer W
    Proc Eur Dial Transplant Assoc; 1980; 17():162-6. PubMed ID: 7243765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral haematocrit modulates erythropoietin production and kinetics of reticulocytes in chronic uraemic patients.
    Walle A; Garcia JF; Niedermayer W
    Proc Eur Dial Transplant Assoc; 1981; 18():633-7. PubMed ID: 7329990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
    Boran M; Dalva I; Yazicioğlu A; Akbay E; Cetin S
    Int Urol Nephrol; 1993; 25(2):197-203. PubMed ID: 8365853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoiesis activity, iron availability and reticulocyte hemoglobinization during treatment with hemodialysis and in subjects with uremia.
    Schoorl M; Schoorl M; Nubé MJ; Bartels PC
    Clin Lab; 2006; 52(11-12):621-9. PubMed ID: 17175894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
    Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A
    Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of fibrinogen receptors and GPIIb molecules on uraemic platelets: effect of recombinant human erythropoietin therapy.
    Krzesłowska J; Rysz J; Cierniewski CS; Luciak M
    Nephrol Dial Transplant; 1995; 10(5):653-6. PubMed ID: 7566578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor I: a modulator of erythropoiesis in uraemic patients?
    Ureña P; Bonnardeaux A; Eckardt KU; Kurtz A; Drüeke TB
    Nephrol Dial Transplant; 1992; 7(1):40-4. PubMed ID: 1316579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The variable role of erythropoietin deficiency in the pathogenesis of dialysis anaemia.
    Radtke HW; Erbes PM; Fassbinder W; Koch KM
    Proc Eur Dial Transplant Assoc; 1977; 14():177-83. PubMed ID: 600954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of oral and intravenous iron therapy in haemodialysis patients.
    Jenq CC; Tian YC; Wu HH; Hsu PY; Huang JY; Chen YC; Fang JT; Yang CW
    Int J Clin Pract; 2008 Mar; 62(3):416-22. PubMed ID: 17511797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of various factors that could have an impact on the treatment with erythropoietin of hemodialysis anemia].
    Fernández-Gallego J; Ramos B; Ruiz A; Contreras J; Alvarez Bustos G; López de Novales E
    Nefrologia; 2000; 20(2):164-70. PubMed ID: 10853198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the erythropoietin-hematocrit feedback control operative in chronic renal failure?
    Walle AJ; Weiland E; Proppe D; Niedermayer W
    Nephron; 1982; 31(3):229-35. PubMed ID: 7121669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of analyzing reticulocyte subpopulations in polycythemia].
    Ataulfo González F; Bermejo A; Sánchez J; Anguita E; Villegas A
    Sangre (Barc); 1997 Oct; 42(5):383-6. PubMed ID: 9424738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
    Sánchez Casajús A; Barrau J; Gómez Alamillo C; Jaurrieta F
    Sangre (Barc); 1990 Feb; 35(1):82-4. PubMed ID: 2333585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reticulocyte response after immediate withdrawal of recombinant human erythropoietin in chronic hemodialysis patients].
    Caramelo C; Soto C; Neira F; López MD; Jiménez S; Albalate M; de Oña R; Llamas P; Deudero JJ
    Nefrologia; 2004; 24(4):351-6. PubMed ID: 15455495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
    El-Khatib M; Duncan HJ; Kant KS
    Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endogenous erythropoietin in patients on regular dialysis therapy].
    Zadrazil J; Bachleda P; Zahálková J
    Vnitr Lek; 1997 Oct; 43(10):649-54. PubMed ID: 9601878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients.
    Khosroshahi HT; Shoja MM; Tubbs RS; Estakhri R; Ardalan MR
    Transplant Proc; 2007 May; 39(4):1051-3. PubMed ID: 17524889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the inhibitory effect of the serum of uraemic children on erythropoiesis.
    Scigalla P; Gudim VI; Ivanova VS; Fedorov NA; Crossmann P
    Acta Haematol; 1980; 64(5):256-64. PubMed ID: 6779482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.